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ABSTRACT
Repopulation and Stimulation of Porcine Cardiac Extracellular
Matrix to Create Engineered Heart Patches
Silvia Juliana Moncada Diaz
Department of Chemical Engineering, BYU
Master of Science
Heart failure is the main cause of death for both men and women in the United States. The only
proven treatment for patients with heart failure is heart transplantation. The goal of this research
is to create patches of tissue that could mimic the function of the native heart to repair the
damaged portions of the heart. In this study, whole porcine hearts were decellularized to create a
3D construct that was recellularized with cardiomyocytes (CM) differentiated from human
induced pluripotent stem (IPS) cells. At day 4 of differentiation, IPS-derived CMs were
implanted onto cardiac extracellular matrix (cECM) and ten days after recellularization, the cells
started to beat spontaneously. After implantation, the progenitor CMs continued to proliferate
and populate the cECM. A live/dead assay showed the potential of the cECM as a scaffold
suitable for recellularization. Confocal microscopy images were taken to evaluate the
organization of the cells within the matrix and the impact of the cECM on the growth and
maturation of the CMs. Representative cardiac Troponin T (cTNT) and vimentin
immunostaining images of CMs derived from iPSCs, on cECM and on standard cell culture
plates showed that the cECM allowed the cells to organize and form fibrils with the fibroblasts,
compared with CMs cultured in regular culture plates. The timeline of implantation of the cells
was a key factor for the development of the heart tissue constructs. Progenitor CMs seeded onto
cECM showed better organization and the ability to penetrate 96 µm deep within the collagen
fibers and align to them. However, mature CMs seeded onto the matrix showed a disorganized
network with very reduced interaction of CMs with fibroblasts, forming two different layers of
cells; CMs on top of fibroblasts. In addition, the depth of penetration of the mature CMs within
the matrix was only 20 µm. To evaluate the impact of the addition of support cells to the CM
monolayer cultures, CMs were co-cultured with human umbilical vein endothelial cells
(HUVEC) and it was demonstrated that at ratios of 2:1 HUVEC:CM the beating rate of the CMs
was improved from 20 to 112 bpm, additionally, the CM monolayer cultures showed a more
synchronized beating pace after the addition of HUVECs. Pharmacological stimulation was
performed on CM monolayer cultures using norepinephrine as a stimulator and the results
showed that the beating pace of the CMs was improved to 116 bpm after 5 minutes of drug
exposure. For future studies, inosculation of the tissue constructs could be performed with the
incorporation of membrane proteins to understand the mechanotransduction of the cells. As a
preliminary study, the action of dual claudins was evaluated with HUVEC cultures and the
results showed the potential of these membrane proteins in the healing of the damaged cell
membrane.
Keywords: heart, decellularization, recellularization, cardiac extracellular matrix, induced
pluripotent stem cells, differentiation, cardiomyocytes, human umbilical vein endothelial cells,
stimulation, norepinephrine.
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1. Introduction
Heart failure, a disabling and frequently fatal disease, is the main cause of death for both
men and women in the United States. Approximately 18 patients die each day because of this
pathology while waiting for a transplant, and more than 5 million individuals currently suffer
from heart failure. The treatment of heart disease requires a novel therapeutic strategy to reduce
mortality and improve the quality of life for heart patients.
Heart disease often results in myocardial infarction. This occurs when blood flow stops to
a part of the heart and the muscle does not receive a supply of nutrients and oxygen, causing
irreversible cell damage. Several attempts have been made to mimic the environment and
function of the native human heart to treat heart diseases. The functional contractile cells that
populate the heart muscle have very limited capacity for regeneration after birth, and therapies
for myocardium regeneration following heart disease and failure are in urgent need. Around one
billion cardiac cells are lost after a heart attack, diminishing the pumping function of the heart
[1]. The only proven treatment for patients whose cell damage progresses to heart failure is heart
transplantation. However, the demand for donor hearts suitable for transplant is much higher
than the supply, creating long waiting lists and leading to patient death in most cases. In addition
to the lack of donor organs, the immune response after transplantation represents another
problem, and in some cases the complete rejection of the new organ is possible.
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Heart tissue engineering is an alternative that holds great promise for those treatments
based on the reconstruction of patient-specific cardiac muscle. Tissue engineering techniques
based on using a patients’ own cells could resolve the immune response problem because the
non-immunogenicity of autologous tissues reduces the likelihood of rejection by the recipient’s
body after transplantation. Regenerative medicine has appeared as a potential alternative to heart
transplants for heart disease patients [2], with the implementation of scaffolds from biomaterials
that can support and create an environment for the heart cells to grow and develop similarly as in
the native human heart. Decellularized scaffolds provide a natural environment, free of
immunogenic factors because of the absence of DNA, and preservation of the heart native
structure which is suitable for cell culture and proliferation [3] could be a potential solution to
treat heart diseases.
Repopulation of heart tissue has been studied for several years. Induced pluripotent stem
(IPS) cells have unique characteristics such as capacity of proliferating indefinitely and the
potential of differentiating into several type of cells. Cardiomyocytes (CMs) are the cells that
perform the beating function in the heart. They can be derived from IPS cells following specific
cell differentiation protocols with the same potential as the CMs found in the native human heart
[4]. Various studies have demonstrated complete differentiation of IPS cells into cardiomyocytes
that express the cardiac phenotype as earlier as day 4 post-differentiation and develop the beating
function similarly as in the human heart [5], and further implantation in heart tissue could be
possible. Some studies have shown that CMs can be implanted in cardiac tissue patches created
from decellularized rat and pig hearts to improve differentiation of the cells [6]. However, the
CMs obtained from these differentiation protocols are not completely mature and show immature
characteristics in morphology, cytoskeletal proteins, and ion channel expression and organization
2

[7]. The lack of these characteristics leads to a desynchronized beating function, and it is an issue
that must be overcome.
In addition, along with CMs, several types of cells are found in the human myocardium.
These cells include human cardiac fibroblasts, smooth muscle cells, and endothelial cells among
others provide support to the CMs. Some studies have proven that coculture of CMs with these
support cells improve engraftment and functional characteristics in in vitro and in vivo models
compared to monolayers of CMs alone [8]. The endothelial cells have a leading role in the
human organism as the promoters of angiogenesis and vascularization. [9]. The portion of the
heart that is affected after a heart attack usually forms a scar and the pumping function of the
heart is decreased severely. Endothelial cells have been studied and several publications have
demonstrated the healing potential of, and the promotion of angiogenesis by HUVECs in diverse
types of damaged tissue. These cells secrete specific growth factors to promote cell proliferation
and vascular development to help reinstate reendothelialization of different tissues of the heart
that are lost after infarction. The survival of CMs and their contractility depend on appropriate
blood supply. In the mature myocardium, each CM is in physical contact with at least one
capillary blood vessel [10]. The addition of supporting cells, such as HUVECs, has proven to
have an influence on the improvement of the contractility rate of the CMs, as well as, on the
synchronization of the pace of the CMs.
One of the biggest challenges in the recellularization of decellularized pig hearts is to get
the cells to beat at synchronized rates similar to the human heart. To accomplish this goal,
mechanical, electrical and pharmacological stimulation of the cells can be performed. In the
human heart, the cells responsible for adapting and adjusting the beating rate of the contractions
are located in the sinoatrial node and are called pacemaker cells. These cells are able to set up
3

and maintain the pace of the entire heart muscle preventing arrythmias or other beating disorders,
allowing the blood to be pumped correctly to the rest of the body. Since the movements of the
cardiac muscle are involuntary, they are controlled by the sympathetic branch of the nervous
system. The membrane of the cardiac cells has G protein coupled receptors, specifically βadrenergic receptors responsible for the excitatory response to specific neurotransmitters such as
norepinephrine, which predominates in the sympathetic pathways that control the cardiac muscle
contractions. The alteration of the release of norepinephrine helps to set the pace and the force of
the cardiomyocyte contraction in response to different events such as exercise or fear. The
implementation of pharmacological stimulation in vitro using drugs such as norepinephrine
could provide a solution to obtain more mature and synchronized CMs that could potentially be
used to populate decellularized scaffolds such as porcine cECM.
This approach, along with the addition of support cells to the in vitro CMs cultures, could
be implemented in the creation of an engineered heart to enhance the function of the beating
heart tissue and provide a step further in the discovery of a regenerative therapy that can improve
and enhance the life of heart patients.

4

2. Literature Review
2.1 Whole Heart Decellularization
Biologic scaffold materials composed of extracellular matrix (ECM) are typically
obtained in a process that involves decellularization of tissues and organs. Different protocols
have demonstrated the ability to completely decellularize tissues or organs by using physical,
chemical or enzymatic agents to lyse cells and remove them from the tissue [11]. Removing
cellular remnants may prevent an immune response while preserving the underlying structure
[12,13]. Preliminary studies have shown the feasibility of creating complete decellularized rat
hearts to be used as scaffolds to support and promote cardiac cells [14].
Porcine hearts are similar to human hearts in terms of anatomy, size and protein
expression, and they can provide an ideal scaffold for engineering human-size hearts. The ECM
is a three-dimensional meshwork of proteins and polysaccharides that imparts structure and
mechanical stability to tissues. It is composed of a set of 367 proteins that represent the core
components, and mediate a map for physical interactions [15]. It has been demonstrated that
cardiac extracellular matrix (cECM) scaffolds derived from decellularized pig hearts can support
the attachment and growth of human endothelial cells and fibroblasts [3].
In order to obtain a cECM that can complete this function, DNA must be almost
completely removed from the matrix to ensure a non-immunogenic response [16]. In addition to
this, ECM components such as collagen and GAGs must remain in the matrix to provide support
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for the attachment of cardiac cells. Cytotoxicity tests must be completed to ensure blood
compatibility of the decellularized heart tissue. There are different assays based on human blood
hemolysis that have been developed to measure the remaining cytotoxicity of the cECM.
The chemicals used to decellularize a tissue can have different effects on the tissue
ultrastructure, mechanical behavior and biochemical composition, and may affect the host
response [17]. Thus, it is important to remove the residual chemicals after the decellularization
process to reduce the possibility of producing a cytotoxic cECM. Momtahan et al (2016)
developed a method to examine the cytotoxicity of acellular cECM. The hemolysis assay used in
their study directly measured the cell death caused by the detergents used in the decellularization
process. The study showed that detergents such as Triton-X and SDS, which are commonly used
in decellularization protocols, need to be removed to obtain a non-cytotoxic cECM that can be
viable for implantation. The hemolysis assay is a method that can be used to examine the
cytotoxicity of a tissue or scaffold due to residual detergents.

2.2 Cell Culture, Differentiation and Recellularization
2.2.1

Cardiomyocyte Differentiation from IPS Cells

Human embryonic stem cells have the potential to differentiate into all of the cell types of
the body and may be useful as a source of cells for transplantation or tissue engineering [18];
however, their use is often perceived as unethical. Cardiomyocytes can also be created from the
differentiation of IPS cells that are created from an adult patient’s own cells – an ethical source
of cells. However, current cardiac differentiation protocols exhibit variable success across
different IPS lines. These protocols usually use a cECM in combination with growth factors to
promote cardiogenesis [5]. It has been proven that dynamic cECM promotes epithelial6

mesenchymal transition of human IPS cells and complemented growth factor signaling to enable
robust cardiac differentiation [19]. Lu et al (2013) reported that multipotential cardiovascular
progenitor cells migrate, proliferate, and differentiate into cardiomyocytes after 20 days of
perfusion into cECM. They showed that cECM promoted cardiomyocyte proliferation,
differentiation, and myofilament formation from the repopulated human multipotential
cardiovascular progenitor cells [6].
Burridge et al (2014) reported complete differentiation of IPS cells into cardiomyocytes.
The protocol (CDM3) they used to differentiate the cells consisted of three components: basal
medium (RPMI 1640), L-ascorbic acid 2-phosphate, and rice-derived recombinant human
albumin. Cardiomyocytes produced under their protocol were positive for cardiac markers
troponin T-positive (TNNT2) and α-actinin. Contraction of the CMs began at days 7-9 of culture
and minimal cell death was observed. The characterization of differentiated CMs showed that at
days 15-20 the cells had an atrial-like action potential, and at days 30-35 of culture CMs
demonstrated the phenotype of ventricular-like cells. Although this protocol produces immature
CMs, the cells progressed from an unspecified cardiomyocyte precursor phenotype to a
predominantly ventricular phenotype.
CMs obtained from differentiation protocols are usually in an immature stage and cannot
carry the beating function as well as mature CMs do in the adult heart. Mature CMs may better
reflect the physiology of the adult heart and therefore be more useful in disease modeling. There
are several ways to promote the maturation of CMs derived from IPS cells [20]. Yang et al
(2014) demonstrated that after applying electrical stimulation and mechanical loading on the
intermediate CMs, the cells displayed higher conduction velocity, contraction force and
increased calcium transient kinetics. In addition to these stimulation methods, pharmaceutical
7

stimulation could be considered to improve the synchronized beating function. Altogether, these
development characteristics can enhance the beating function of the CMs in the cECM.

2.2.2

Coculture of Cells

In the native human heart, the CMs contribute to the beating function, but the cardiac
muscle needs other support cells to achieve the correct function of the heart. There are several
types of cells that contribute to the overall beating function, such as endothelial cells, cardiac
fibroblasts, and smooth muscle cells. Several authors have demonstrated that the behavior of the
CMs is influenced by the presence of these support cells. For example, Polonchuk et al (2017)
showed that the ratio of coculture of different populations of support cells, specifically
endothelial cells and cardiac fibroblasts is critical to successfully model the behavior of the
human heart [8]. Adult CMs comprise 30% of the total cell population in the native human heart,
while endothelial cells represent 10%, and cardiac fibroblasts the remaining 60%. The authors
showed that primary CMs do not survive in culture for extended periods without supporting
cells. Endothelial cells play a role in forming the vasculature of the heart, while cardiac
fibroblasts appear to play a supportive role for the vascular network formation.

2.2.3

Human Umbilical Vein Endothelial Cells (HUVECS) for Recellularization of
Cardiac ECM

The main goal for all processes involving heart tissue engineering is to be able to create
an organ that can be transplanted into patients with heart failure. To do this, the engineered heart
must have the same behavior and functionality as a native human heart. To accomplish that, in
8

addition to the differentiation and repopulation of cECM with cardiomyocytes derived from IPS
cells, the use of HUVECs could help to achieve this goal. It has been reported that HUVECs
express brain derived neurotrophic factor (BDNF) as well as other growth factors that enable
axonal growth in skeletal muscle [21].
Another growth factor, vascular endothelial growth factor (VEGF), which is also
expressed by HUVECs, promotes angiogenesis in damaged tissues and facilitates the crosstalk
between neural and vascular systems [22,23]. This communication between the neural and
vascular systems may allow the heart tissue to function as well as a native heart, and could
further contribute to the creation of a transplantable heart from decellularized pig hearts. Other
studies have demonstrated the role of HUVECs in the reendothelialization of different tissues of
the body to promote cell proliferation and vascular development [24,25,26].
Shvartsman et al. (2014) reported that VEGF, in addition to other growth factors,
promotes the innervation of skeletal muscles after ischemic injuries. VEGF has been identified as
a potential component that aims at restoring neural functions in damaged tissues. In addition,
nerve growth factor (NGF) and glial-derived neurotrophic factor (GDNF) have roles in blood
vessel growth and maturation in skeletal muscles. In this study, researchers demonstrated that
HUVECs secrete NGF, GDNF, and VEGF, which are essential in the revascularization of injured
tissue. These growth factors also promote axonal growth in tissues and help to maintain the
crosstalk between the neuromuscular and the vascular systems.
Even though the biotechnology that uses HUVECs as precursors of vascularization
processes in tissues hasn’t been studied in heart tissue, the research that has been done in other
types of tissue from the human body could help to develop a similar technology that can be
applied in engineered hearts.
9

2.2.3.1 HUVECS Culture
Several methods have been reported to cultivate HUVECs and promote angiogenesis in
damaged tissue [27]. Hadjizadeh et al (2017) reported successful angiogenesis using multilayer
surface-modified polymer fibers, and two different methods of cell seeding by HUVECs. They
proposed a protocol for culture of the HUVECs. The cell culture protocol consisted of culture
medium (M199) containing sodium bicarbonate (2.2mg/mL), sodium heparin (90µg/mL),
penicillin/streptomycin (100 U/100µg/mL), 10% fetal bovine serum (FBS), L-glutamine (2mM),
and endothelial cell growth supplement (ECGS). The cells were kept in an incubator at 37°C and
5% CO2. In addition, they studied two different methods of cell seeding by HUVECs: In the first
one, HUVECs, fibrin gel matrix and fibers were combined simultaneously. They found that by
using this method, angiogenesis did not occur after 10 days of culture period. In the second
method, the HUVECs were seeded in a sandwich between two layers of fibrin gel matrix with or
without fibroblast cell monolayer over the fibrin gel. The study showed micro-vessel formation
after day 5 of the culture period and concluded that the presence of fibroblasts facilitated the
endothelial progression.
Sanchez-Muñoz et al (2015) studied the angiogenesis of skin using HUVECs and human
adipose mesenchymal stem cells (hADMSCs). The protocol that they proposed for the culture of
HUVECs consisted of M199 medium, and supplements composed of 10% FBS, 10 U/mL
heparin, and 2.5 µg/mL endothelial cell growth factor (ECGF). The cells were kept in an
incubator at 37°C and 5% CO2. The culture medium was changed 3 times a week and the cells
were used at 3-4 passages. They proposed 3 different models for angiogenesis of the tissue. The
first model contained hADMSCs, the second model contained HUVECs and the third model
contained HUVECs and hADMSCs. All of the three models also contained fibroblasts and
10

keratinocytes, which express VEGF that aim in the angiogenesis. Researchers observed that
capillary-like structures (small channels) were formed only in model 3, and the cells proliferated
and adhered to the entire tissue layer. Several growth factor levels, including VEGF, hepatocyte
growth factor (HGF), and platelet-derived growth factor-AB (PDGF-AB), increased by 3-, 4and 3-fold, respectively, at day 15 of cell culture.

2.3 Stimulation of Cardiac ECM
Several approaches have been pursued to improve the beating function of the CMs
implanted in heart tissue patches and accelerate their maturation. The different approaches to
mature IPS-derived CMs implanted in cECM that can be considered are mechanical, electrical,
and pharmacological stimulation. The combination of these types of stimulation in a 3D matrix
has produced CMs that acquire a physiological cell hypertrophy, mature their contractile
apparatus, and improve Ca2+ handling properties [28].

2.3.1

Mechanical Stimulation

The ultimate goal of tissue engineering is to be able to create implants similar to native
tissue. It is essential to use physiological stimuli to improve the quality of the tissue constructs.
Mechanical stimulation of cardiac tissue patches leads to a maturation of immature CMs
differentiated from IPS cells. Mature CMs cultivated in vitro must exhibit similar functions to
CMs in the adult myocardium. The cardiac environment is highly mechanically active with
spontaneous contractions and stretching can be used to mimic these conditions in the heart tissue
constructs [29]. It has been demonstrated that application of mechanical stretch improves
11

contractile function, alignment of CMs along the stretch axis, and gene expression of CM
markers [30].
Lux et al (2015) accomplished maturation of CMs implanted in tissue constructs by
mechanically stretching the cECM during cultivation of CMs isolated from rat hearts.
Mechanical stimulation was used to alter passive muscle loading. It is commonly utilized to
mimic the most important aspects of the way CMs work in the heart. In this study, researchers
used a matrix consisting of a combination of the small intestine submucosa from pigs with
preserved mesenteric arterial and venous pedicles – named Biological Vascularized Matrix
(BioVam). They seeded the CMs isolated from rat hearts into the matrix and prepared it for
mechanical stretch. The initial experiments were conducted at 2%, 5%, 10%, and 20% stretch to
observe the impact of the mechanical stimuli on the contractile function of the matrix. They
found that 2% stretch did not induce any changes in the contractile function while 10% and 20%
stretch decreased the contractile function of the cardiac constructs. Thus, all experiments were
conducted at 5% uniaxial cyclic stretch stimuli (2.2 mm) at 1 Hz for 48 hours starting at day 8 of
culture. An analysis at the cellular level demonstrated a strong alignment of the cells parallel to
the direction of applied mechanical stimulation which increased the contractile function in the
cardiac constructs.

2.3.2

Electrical Stimulation

Cardiac function depends on the appropriate timing of contraction in the different regions
of the heart. To maintain these functions, electrical activity in each region is adapted to its
specialized function. In the adult human heart, CMs are classified as ventricular-, nodal-, and
atria-like cells based on their action potentials. IPS-derived CMs from various protocols consist
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of a mixture of the three different phenotypes with ventricular-like cells being the predominant
class of CMs. As mentioned before, IPS-derived CMs produced in vitro exhibit an immature
state and need to achieve maturation. Cell culture in combination with electrical stimulation
could enhance the maturation and ameliorate the beating function of the CMs.
Mature mammalian myocardium exhibits both a positive force-preload relationship and a
positive force-frequency (FFR) relationship, which are important for the contractile performance
of healthy myocardium. Heart failure occurs when both mechanisms are lost in combination with
fundamental alterations in excitation-contraction coupling. Despite the evidence of organotypic
structural and molecular maturation, cECM repopulated with CMs have not shown a positive
FFR. The positive FFR is dependent on the maturity of the intracellular calcium stores, the
sarcoplasmic reticulum, and T-tubulation. Heart muscle development and maturation in the
human body depend on electro-mechanical inputs, so by supporting auxotonic contracting
function through mechanical loads and electrically stimulating at frequencies observed in
neonatal hearts, the beating rate of cECM seeded with CMs could be enhanced [31].
Godier-Furnemont et al (2016) achieved maturation function of engineered heart muscle
(EHM). They proposed a mechanism of maturation consisting of a combination of mechanical
and electrical stimulation within the culture protocol. They constructed EHM from mixtures of
collagen type I, Matrigel and neonatal rat heart cells. They stimulated the EHM with auxotonic
contractions at frequencies between 2 and 6 Hz. EHM was stimulated first just with auxotonic
contractions and at day 8 of culture, spontaneous beating frequencies of 1.23 Hz were observed.
This proved that incorporation of mechanical stimulation in culture improves the beating
function of the EHM. After day 8 of culture, electrical stimulation was incorporated. Frequencies
of 2, 4 and 6 Hz were delivered to the EHM. After 5 days of electro-mechanical stimulation at 4
13

Hz, a marked drop in spontaneous beating frequency – an indicator of maturation was observed.
This study also demonstrated a positive FFR in the EHM electro-mechanically stimulated at 4
Hz, demonstrating that stimulation is crucial for functional maturation. CMs stimulated at 4 Hz
also showed calcium transients similar to CMs derived from a 13-day old rat myocardium. The
sarcoplasmic reticulum calcium storage and release capacity was enhanced in samples stimulated
at 2 and 4 Hz, demonstrating maturation in myocardial function.

2.3.3

Pharmacological Stimulation

CMs derived from IPS cells have an enormous potential for therapeutic applications.
However, their immature stage after differentiation restricts their potential. Various secretions in
the human body (e.g. hormones) are essential for optimal heart growth and development. Some
scientists have proven that hormones such as Tri-iodo-L-thyronine (T3) aid in the development
of a healthy heart [32]. T3 is a hormone that represses expression of fetal genes in neonatal CMs
to enhance normal cardiac maturation. Abnormally high T3 levels in humans can lead to various
complications such as decreased cardiac output, growth restriction, neuropathologies and
tachycardia.
Yang et al (2014) showed how CMs treated with T3 increased their size, anisotropy and
sarcomere length. They also demonstrated that the cells had lower proliferative activity, higher
contractile force generation, enhanced calcium handling properties and increased mitochondrial
respiration capacity. Their results showed that the cells increased their size from 604 µm2 to 991
µm2, demonstrating that CMs exhibited a more mature morphology when they were treated with
T3. The importance of cell size is reflected in the impulse propagation, maximal rate of action
potential depolarization and total contractile force. The researchers in this study also proved that
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the contractile force was improved by treatment with T3. The twitch force increased from 7.5
nN/cell to 12.3 nN/cell. CMs treated with T3 displayed shorter time to peak contraction and
significantly decreased relaxation time. This study suggested that the hormone T3 promotes the
maturation of CMs derived from IPS cells by the improvement of morphological and functional
characteristics of CMs.
Other molecules produced by the human body could contribute to the development of the
morphological and functional characteristics of CMs derived from IPS cells [33].
Catecholamines, such as epinephrine and norepinephrine, are hormones produced by the medulla
of the adrenal gland and they help in the activation of sympathetic responses in the human body,
particularly inotropic and chronotropic responses. Those responses are involved in changes of
beating rate by the heart. The β-receptors are responsible for the responses and the changes in
cardiac frequency in the heart, particularly β1-receptors. Drugs that interact with these receptors
are called β-blocking drugs, and aid in altering the beating cardiac function. Isoproterenol is an
example of a β-blocker and is a potent vasodilator that, along with epinephrine and
norepinephrine, can help modulate the beating heart.
Fan et al (2016) demonstrated that CMs exposed to short periods of pharmacological
stimuli with epinephrine or norepinephrine increased their contraction rate, reaching a maximum
at 5 min, followed by a slow decline. In contrast, the exposure of CMs to the drugs for time
periods of 60 minutes did not increase the contraction response. Their results indicate that
continuous exposure of the cells to the stimulator caused functional desensitization of CMs and
prevented the contraction rate to increase. The exposure of the CMs to these stimulation drugs
could enhance the contraction rate of the CMs; therefore, the potential of the cells to beat within
the cECM could also improve. This specific type of stimulation in combination with other
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stimulating mechanisms enhance the possibility to obtain patches of cECM that could mimic the
function of the human heart.

2.4 Summary
There are many aims that must be achieved to obtain a scaffold that can function as the
human heart does. First, the cECM obtained from the decellularization of whole animal hearts
must meet specific characteristics. For example, DNA must be removed from the tissue to avoid
host rejection. Also, the detergents used to ‘wash’ the heart must preserve the collagen
meshwork to make a functional cECM. Whole decellularization of pig hearts has accomplished
these characteristics [3].
Second, the cECM needs to be repopulated with CMs that can carry the beating function
the same way CMs do in the human heart. Human CMs finish their proliferation process at 7
months of age, so when myocardial infarction occurs, the cells in the heart are not able to heal
and regenerate. Various protocols have been developed to completely differentiate IPS cells into
CMs. However, most of the CMs obtained in these protocols produce immature CMs that cannot
perform the beating function correctly, and desynchronized beating tissue patches are observed.
Some authors have proposed alternative approaches to mature the CMs lines produced in
differentiation protocols [20]. Mechanical loading and electrical stimulation have been proposed
as pathways to produce mature CMs [20]. Pharmaceutical stimulation could also be considered
as a method to mature CMs [33].
Lastly, rapid and sufficient blood perfusion is necessary for the integration and survival
of in vitro bioengineered tissue constructs. This is also important when looking at the possibility
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of implantation of tissue patches into a living organism or complete organ transplant. HUVECs
have been demonstrated to be capable of secreting several growth factors that are essential in the
angiogenesis or blood vessel formation of the tissues in the human body, as well as, provide
support for the CMs in the heart muscle allowing them to perform their function better. These
cells require special culture protocols that researchers have developed. The expression of these
growth factors promotes angiogenesis in injured tissues that can also connect the vascular and
nervous system providing the support necessary for the CMs to perform their function correctly.
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3. Objective
The objective was to define first the conditions for recellularization of decellularized
porcine cECM scaffolds with CMs differentiated from human peripheral blood mononuclear
cell-derived (PBMC) IPS cells to derive patches of functional heart tissue that mimic the native
human heart. Second, the improvement of the beating function of the CM monolayers in
coculture with HUVECs and pharmacological stimulation using adrenergic drugs.

3.1 Tasks
1. Demonstrate that the CMs express better attachment characteristics when seeded on
cECM at the progenitor stage.
a. Recellularization of tissue patches with progenitor and mature cardiomyocytes
i. Culture of progenitor (day 4 post differentiation) and mature (day 15 post
differentiation) stage CMs on cECM to evaluate the differences in
attachment characteristics of the cells in both scenarios.
2. Demonstrate that the beating function of the CM monolayers can be increased from 10 to
70-120 beats per minute in a synchronized manner.
a. Coculture of CMs with HUVECs
i. Ratios of HUVECs and CMs of 1:1 and 2:1.
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b. Pharmaceutical stimulation of the CMs
i. Norepinephrine in concentrations of 10 and 20 µM in intervals of 10
minutes.
c. Mechanical stimulation prototype

3.1.1

Rationale and Hypothesis

In the native human heart, the CMs contribute to the beating function, but the cardiac
muscle needs other support cells to achieve the correct function of the heart. Primary CMs do not
survive in culture for extended periods without supporting cells. The addition of HUVECs to the
cultures can improve the beating function of the CMs. The timeline for the recellularization of
the tissue constructs with the cells is also an important factor in obtaining beating patches with
improved functionality to be transplanted to a patient. Moreover, the exposure of the cells to
drugs such as norepinephrine a known neurotransmitter that plays a significant role in the
improvement of the heart rate, can also contribute to increase the synchronized beating function
of the cells.
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4. Recellularization of Cardiac Extracellular Matrix
Several attempts have been made to create a regenerative therapy that could mimic the
environment and function of the native human heart to treat heart failure diseases. Although the
differentiation of IPS cells into CMs has been done for several years [2,3,14,31,34] with positive
results regarding the beating function of the cells, the implementation of biomaterials such as
decellularized scaffolds to create beating constructs must be done. In this study, the effectiveness
of porcine cardiac extracellular matrix (cECM) as a supporting scaffold for cardiomyocytes
(CMs) differentiated from human induced pluripotent stem cells (iPSCs) was demonstrated.
Acellular cECM was produced in an automated, pressure-controlled whole heart
decellularization apparatus [3] and human iPSCs generated from peripheral blood monocytes [4]
were used for CM differentiation. Differentiated CMs on cECM exhibited improved phenotype
maintenance, elongation, arrangement, and beating functions compared to CMs cultured in
regular cell culture plates, and CMs seeded onto cECM 15 days after differentiation.

4.1 Materials and Methods
4.1.1

Decellularization of Porcine Hearts and Tissue Preparation

Whole porcine hearts from 6-month-old female Yorkshire Cross swine were harvested
from a local abattoir following approved protocols for safety and animal care. In order to obtain
acellular cECM, decellularization of hearts was achieved using an automated pressure-controlled
apparatus, similarly to studies previously published by Momtahan et al [3]. Following
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decellularization, the hearts were dissected to separate the left ventricle, and a cryostat machine
(HM525 NX, Thermo Scientific®, Pittsburgh, PA) was used to obtain round slices (10 mm
diameter, 300 µm thickness) of decellularized cardiac tissue. The samples were mounted on 10
mm diameter glass coverslips (Agar Scientific, Stansted Essex, UK) and placed in a 48-well
plate containing 1 ml of 70% Ethanol solution. The tissue samples were treated with 1 ml of
antibiotic solution containing 100 U/mL penicillin, 100 µg/mL streptomycin, 25 µg/mL
amphotericin B in 75% ethanol to prevent bacterial and fungal contamination. The plates were
incubated at room temperature for 3 h in a rotary shaker, and each well was washed 3 times with
1 mL sterile Dulbecco’s phosphate-buffered saline (DPBS, Gibco™). Thereafter, the tissue
culture plates were centrifuged at 200 x g for 4 minutes to remove trapped bubbles, and 500 µL
of Fetal Bovine Serum (FBS, Gibco™) were added to each well. The plates were stored at 4°C
for up to two weeks.

4.1.2

IPS Cell Culture and Cardiomyocyte Differentiation

Human IPS cells reprogrammed from peripheral blood monocytes (PBMCs)
cryopreserved at -190°C were obtained from the University of Utah Cardiovascular Research and
Training Institute (CVRTI, Salt Lake City, UT). The cells were thawed and seeded in 6 wellplates coated with a DPBS -Vitronectin (VTN-N, Gibco™) solution (5.5µl VTN-N per ml
DPBS). Cell cultures were maintained with TeSR™-E8™ Medium (StemCell Technologies™)
in an incubator (Panasonic® MCO-19M-UV) at 37°C, 5% CO2, and medium changes were
performed daily. Cell passage was performed at 90% confluency using StemPro® Accutase®
(Gibco™) as a dissociation reagent to detach the cells from the plate, and the culture plates were
incubated for 5-6 min. Cell suspensions were centrifuged at 800 RPMs for 5 minutes, and 1:4
21

dilutions were adjusted to reach confluency every 3-4 days. To improve cell survival and
attachment, Rho-associated protein kinase (ROCK) inhibitor (RevitaCell™, Gibco™) was added
to the cell suspensions for the first 24 h, at every passage and after thawing.
Cardiomyocyte differentiation was performed once the IPS cells reached 90%
confluency. TeSR™-E8™ Medium was replaced with Cardiomyocyte Differentiation Medium A
(StemCell Technologies™) supplemented with Corning® Matrigel® (10µL/mL). On day 2, the
medium was replaced with Cardiomyocyte Differentiation Medium B (StemCell
Technologies™) and on days 4 and 6, the medium changes were performed with Cardiomyocyte
Differentiation Medium C (StemCell Technologies™). At day 8, small areas of beating cells
were visible, the medium was replaced with Cardiomyocyte Maintenance Medium (StemCell
Technologies™) and renewed every 2 days.

4.1.3

Recellularization of Decellularized Cardiac Extracellular Matrix

On day 4 of differentiation, the healthiest CMs were dissociated from the culture plates
using TrypLE™ Enzyme (Gibco®). One ml of enzyme was added to each well and aspirated
immediately to assure just enough enzyme to be in contact with the cells. The cell cultures were
incubated for 5 min at 37°C in 5% CO2. The cell monolayer was resuspended in Cardiomyocyte
Differentiation Medium C supplemented with ROCK inhibitor (RevitaCell™, Gibco™). A cell
counter was used to count the cells and the cell suspensions were diluted to 1x106 cells/ml. The
tissue plates were incubated for 1 h at 37°C prior to seeding, and 1 ml of cell suspension was
added to each well. Medium change was performed one day after the seeding to prevent the cells
from becoming dependent on the ROCK inhibitor. Thereafter, the medium was changed every
two days as directed by the manufacturer. To evaluate the survival of the cells on the matrix, a
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live/dead assay (Biotium) was performed at days 7 and 20 post recellularization on tissue
constructs following the protocol from the manufacturer. Depending on the cell line, the tissue
constructs started to beat 10-15 days post-seeding and the beating function of the cells was
visually controlled and quantified. To evaluate the impact of the cECM on the cells (maturation
and organization) the CMs were also seeded onto the matrix following the same protocol at days
10-15 post differentiation depending on the health of the cells.

4.1.4

Histology and Immunofluorescence Imaging

Recellularized ECM and 2D monolayer samples were washed with phosphate buffered
saline (PBS, GibcoTM) and fixed with 4% paraformaldehyde at room temperature for 10 min (2D
monolayers) or 60 min (cECM). Samples were further washed three times with PBS solution and
permeabilized with a PBS solution containing 0.2% Triton® X-100 (Fisher Scientific) for 30 min
(2D monolayers) or 60 min (ECM). Afterwards, samples were blocked for 60 min using a PBS
solution containing 2% fetal bovine serum (FBS, Sigma Aldrich, St. Louis, MO). Samples were
then incubated overnight at 4°C in a PBS solution containing 2% FBS, monoclonal anti-cardiac
Troponin T (cTnT, RV-C2, 1:50, F5D; 1:50; Developmental Studies Hybridoma Bank, DSHB),
and monoclonal anti-Vimentin (V6630, 1:200, Sigma Aldrich, St. Louis, MO). The following
day, the samples were washed three times with PBS and incubated for 60 min with a goat antimouse IgG2b Alexa Fluor® 647 (A21241, 1:500, Invitrogen Eugene, OR), and goat anti-mouse
IgG1 Alexa Fluor® 488 (A21121, 1:500, Invitrogen Eugene, OR), diluted in a PBS solution
containing 2% FBS. Following the three PBS washes, the samples were mounted using ProLong
Gold Antifade Reagent (Invitrogen Eugene, OR). A two-track protocol was used to obtain 3Dstacks using a Zeiss LSM 880 Airyscan confocal microscope (Carl Zeiss, Jena, Germany)
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equipped with a 20x lens. Images were processed using Imaris software (v6.1.0, Bitplane AG,
Zurich, Switzerland).

4.2 Results
4.2.1

Recellularization of Decellularized cECM

At day 4 of differentiation, the progenitor CMs cell cultures were passaged onto cECM to
continue and complete the differentiation process. The cells started to beat 15 days post seeding
on the matrix, contrary to what regularly happens when the cells are differentiated in cell culture
plates, in which they beat after 8-10 days of differentiation. A live/dead staining assay was
performed 7 and 20 days post seeding (11 and 24 days post differentiation) to evaluate the
cytotoxicity of the matrix, and the results are shown in Figure 1.

A

B

Figure 1. Live/dead Assay performed on cECM populated with CMs at days (A) 7 post
seeding and (B) 20 post seeding. Scale bars represent 100 µm.

In a progenitor stage, CMs continued to proliferate up to day 15 post differentiation when
they started to attain a more mature phenotype and stop proliferation. For the recellularization of
the cECM, one million progenitor CMs were seeded onto matrix as previously described. Figure
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1A shows the cells 7 days after seeding, at which point, CMs were in a progenitor stage and they
continued to expand and populate the cECM. When the cells reached a more mature phenotype
(after day 20 post seeding), they stopped growing and proliferating, nevertheless the cells had
expanded creating a bigger and denser population within the cECM up to ~95% of its area (Fig.
1B). The beating function was recorded for the samples and the cells registered a beating rate of
13 bpm at day 7 post seeding and 44 beats per minute at day 20 post seeding. The live/dead assay
showed the survival of the CMs on the tissue matrix after recellularization proving that the
cECM provides a suitable environment for cell growth with no cytotoxic effects for the cells.
Confocal microscopy images were taken to evaluate the organization of the cells within
the matrix and the impact of the cECM on the growth and maturation of the CMs. Representative
cTNT and vimentin immunostaining images of CMs derived from iPSCs, on cECM and on
standard cell culture plates are shown in Figure 2. The cells showed improved arrangement and
organization when differentiated onto cECM (Fig. 2A and 2B, white arrows) compared with
CMs differentiated in regular cell culture plates (Figure 2C and 2D). Cardiomyocytes (TNNT2,
red) differentiated on the porcine cECM oriented into longitudinal fibrils that interdigitated with
longitudinal strands of fibroblasts (Vimentin, green) in the same direction of the collagen fibers
of the cECM. By contrast, cardiomyocytes differentiated on standard cell culture plates
associated into 2D clusters/monolayers of beating cells, without any specific orientation (Figure
2 C, D).
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Figure 2. Cardiomyocytes differentiated on decellularized porcine cECM formed
longitudinally oriented fibrils. 3D reconstructed confocal images of cardiomyocytes
differentiated on decellularized porcine cECM (A, B) and 2D monolayers differentiated on
a standard cell culture plate (C, D); see Materials and Methods for details. Image in D is
magnified region denoted by white box in C. Confocal images were obtained using Zeiss
LSM 880 Airyscan confocal microscope, 20X. Scale bar represents 50 µm.

To evaluate the impact of the cECM on the maturation and organization of the cells, the
CMs were seeded onto the matrix as progenitors (4-5 days post differentiation) and as fully
differentiated CMs (mature cells, 15 days post differentiation). Confocal microscopy images
were taken and figures 3 and 4 show the results of the cultures for both scenarios.
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Figure 3. 3D reconstructed confocal images of cardiomyocytes differentiated on
decellularized porcine cECM show a better organization (A, B) when seeded as
progenitors, compared with cardiomyocytes seeded on decellularized porcine cECM (C, D)
as mature cells; see Materials and Methods for details. Confocal images were obtained
using Zeiss LSM 880 Airyscan confocal microscope, 20X. Scale bar represents 50 µm.

When the CMs were seeded as progenitors, the organization of the cells (Fig 3A and 3B)
was better. The cells interacted and formed a network with longitudinal strands of fibroblasts and
appeared to intercalate with them. On the contrary, when the CMs were seeded as mature cells,
they presented a different pattern than fibrils (Fig. 3C, and 3D); instead they formed clusters of
cells on top of the fibroblasts, and no significant interaction was observed between the CMs (red)
and the fibroblasts (green) compared to when progenitors CMs were seeded onto the cECM. The
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pattern observed with seeded mature CMs was similar to the one observed when the CMs were
differentiated and kept in regular culture well plates (Fig 2C and 2D).

Another factor that is important when comparing the behavior of the cells at different
seeding timelines is the ability of the CMs to penetrate deep and between the collagen fibers of
the cECM. To evaluate this issue the depth of penetration of the CMs in the cECM was measured
on confocal microscopy images.

Progenitor CM

Mature CM

A

C

B

D

Figure 4. 3D reconstructed confocal images of cardiomyocytes differentiated on
decellularized porcine cECM showed a deeper penetration within the matrix (A) when
seeded as progenitors, compared with cardiomyocytes seeded on decellularized porcine
cECM (B and C) as mature cells; see Materials and Methods for details. Confocal images
were obtained using Zeiss LSM 880 Airyscan confocal microscope, 20X. Scale bar
represents 50 µm (A) and 70 µm (B, C).
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Progenitor CMs seeded onto the cECM were able to penetrate deeper within the matrix
compared with mature CMs. The mechanism of migration of the cells is thought to be mostly by
gravity following the tortuous path of the pores and gaps through the tissue construct. Progenitor
CMs are single cells and this characteristic also gives them the facility to move through the
collagen fibers of the matrix. Contrary, the fully differentiated CMs organize in clusters,
connected to each other through transmembrane proteins and that hinders the ability of the cells
to migrate within the collagen matrix. The penetration of the cells was measured in 3 different
samples, 4 measurements in each one (n=12) for both the progenitor and mature CMs. The
progenitor CMs were able to penetrate the matrix 96.39±8.34 µm (Fig 4A, white arrows), while
the mature CMs were able to penetrate only 20.13±4.5 µm (Fig 4, C white arrows). In Figure 4C,
there was a small portion of CMs (red) that penetrated deeper when seeded as mature CMs
(yellow arrow); 56 µm; however, this was not significant when comparing that small portion
with the overall penetration ability of the mature CMs. Comparing the thickness of the cECM
which was 300 µm and the ability of the cells to penetrate the cECM in both scenarios, the
progenitor cells penetrated 32.1±2.8% of the depth of the matrix while the mature cells were able
to penetrate only 6.7±1.5%.

4.3 Discussion
The decellularized porcine cECM used as a scaffold for cardiac tissue regeneration is a
promising biotechnology for the creation of recellularized beating tissue patches to treat heart
failure disease. The initial experiment proved that the cECM is a suitable environment for cell
growth and development. Following recellularization at early stages of differentiation, the CMS
derived from human IPS cells continued to proliferate, populating the matrix up to 95% of its
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area. The cells seeded onto the cECM were able to completely differentiate into fully mature
CMs and were able to perform their beating function correctly. Cardiomyocytes registered a
beating rate of 13 bpm at day 7 post seeding and 44 beats per minute at day 20 post seeding. The
beating function of the cells diminished once they were seeded on tissue because they need time
to adapt to the dense collagen environment and migrate through the collagen fibers. It is harder
for the cells to acquire a good beating function rapidly, and that is the reason why they take
longer to beat stronger when the tissue is recellularized.
In addition to the survival and ability of the cells to grow and complete differentiation
within the cECM, the alignment of the cells was better and similar to the native human heart
when the cells completed the differentiation process on cECM as shown in figure 2A and 2B.
Cardiomyocytes were able to interact with the fibroblast and form fibrils that are similar to those
found in the human heart. In contrast, when the cells were grown and differentiated on regular
culture plates (Fig 2C and 2D), they did not show an organized pattern in fibrils, nor interaction
with the fibroblasts. Instead, they formed a disorganized network of 2D clusters or monolayer of
beating cells without any specific orientation.
Another important finding from this experiment was the impact of seeding time of the
cells onto the matrix. When the CMs were seeded onto the matrix as progenitor CMs, as they
grew and differentiated, they were able to organize in fibrils along with the fibroblasts. They
showed a specific orientation and were able to contract the collagen fibers of the matrix while
performing their beating function correctly. By contrast, the cells seeded as mature CMs were
not able to organize in fibrils and interact with the fibroblast and the collagen fibers of the matrix
as well as the progenitor CMs (Fig. 3A and 3B). Instead, they formed 3D clusters in a ball-shape
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on top of the fibroblasts creating layers of cells without any significant interaction, with the CMs
on top of the fibroblasts (Fig. 3C and 3D).
Finally, the timeline of seeding also affected the ability of the CMs to burrow within the
cECM. Progenitor CMs were able to complete their differentiation on the matrix and that gave
them the ability to burrow deeper and organize themselves in a better orientation within the
collagen fibers of the matrix. The cells were able to populate the 300 µm thick matrix down to
96.39±9.34 µm of its depth when seeded as progenitors, while mature CMs were only able to
penetrate the matrix 20.13±4.5 µm of its depth. No significant interaction was observed between
the fibroblasts and the CMs; instead, the CMs formed a layer on top of the fibroblasts and more
than half of the population of cells showed no interaction between them (Fig. 4D). The best
approach was to allow the progenitor CMs induced from IPS cells to finish their differentiation
process in the cECM. Since the cells as progenitors have the capacity to proliferate, it is not only
possible for them to burrow within the collagen fibers of the cECM, but also to organize
themselves and create better connections with the fibroblast cells in the vicinity.
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5. Coculture of Cardiomyocytes and HUVECS
In a human heart, the CMs provide the beating function of the organ; however, these cells
need support from other type of cells such as endothelial cells to perform their function correctly.
In this study, the improvement of the beating rate of CMs was demonstrated after the addition of
HUVECs to the 2D monolayer CM cultures at different ratios. Additionally, CMs showed a more
synchronized pace after the addition of the HUVECs to the CMs cultures. The improvement of
the function of the cells was done by analyzing videos, and the beating rate was improved when
CMs were cocultured with HUVECs.

5.1 Materials and Methods
5.1.1

HUVECS Culture

Human umbilical vein endothelial cells (HUVECs) were purchased from Cell
Applications, Inc. (San Diego, CA). Cell culture and expansion was performed in T-75 flasks
using Endothelial Growth Medium (Cell Applications Inc). The cells were thawed and
resuspended in Endothelial Growth Medium (15 ml per flask) and incubated at 37°C in a 5%
CO2 incubator. The medium was changed one day after seeding to remove traces of DMSO, and
thereafter, fresh medium was added to the cell cultures every other day. Once the cell population
reached ~60%, the medium was doubled, and when confluency reached ~90%, the cells were
passaged using Trypsin/EDTA (Cell Applications Inc.) as a dissociation reagent following the
protocol provided by the manufacturer. The cells were centrifuged at 220 x g for 5 minutes, 1:3
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dilutions were adjusted to reach confluency every 4 days, and the medium change was performed
every other day.

5.1.2

Coculture of Cardiomyocytes and Human Umbilical Vein Endothelial Cells.

On day 15 after differentiation started, HUVECs were added to the CM monolayer
cultures in ratios of 2:1 and 1:1 HUVEC:CM which are similar to ratios in the native human
heart [8,10], and the cardiomyocyte maintenance medium was supplemented with VascuLife®
VEGF Endothelial Cell Culture Medium (LifeLine Cell Technology) at the same ratios
(complete medium). The passage of the HUVECs from the T-75 flask to the tissue samples was
performed following the protocol provided by the manufacturer. The cells were counted using a
Mini Automated Cell Counter (MoxiTM, ORFLO Technologies®) and the dilutions were adjusted
to reach the desired concentration. The cells were resuspended in complete medium and seeded
onto the CM cultures. The medium was changed every other day and the beating function of the
cells was visually observed every 24 hours.

5.2 Results
5.2.1

Coculture of Cardiomyocytes and HUVECS

In the native human heart, there are several types of cells beside cardiomyocytes.
Although the CMs are responsible for most of the beating function of the heart muscle, these
other types of cells, known as support cells, play an important role in the correct function of the
heart. Endothelial cells are one of those type of support cells, and in this study these cells were
used to help improve the beating function of the tissue patches. For the first observation, the
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coculture was performed in regular cell culture plates. HUVECs were added in a 2:1
HUVEC:CM ratio 15 days post differentiation and the beating function was observed and
recorded every 24 hours for 8 days. The beating function of the cells was improved by 59% just
24 hours after the addition of HUVECs. However, after 72 hours of coculture, the beating
function was further improved only by 5% compared with the beating pace registered after 24 h
of treatment. Contrary to this, after 120 hours of coculture, the cells improved their beating rate
up to 112 bpm (77% compared with pre-coculture samples). After 192 hours of coculture, the
cells stopped beating but they remained attached to the plate. Figure 5 shows a diagram of the
beating function of the cells. Black markers show the CMs beating rate at 0, 24, 72 and 120
hours post coculture with HUVECs. The orange markers show the behavior of the cells and their
beating rate 48, 96, 144 and 192 hours post coculture.

Figure 5. Beating rate of CMs-HUVECs cocultured cells 2:1 ratio. Orange markers
represent the behavior of the cells at feeding times, black markers represent the behavior
of the cells between feeding times.
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The second observation was performed at culture ratios of 1:1 HUVEC:CM on culture
plates containing CMs on day 15 post differentiation. The beating function of the cells was
recorded every 24 h for 8 days and the results are shown in Figure 6.

Figure 6. Beating rate of CMs-HUVECs cocultured cells 1:1 ratio. Orange markers
represent the behavior of the cells at feeding times, black markers represent the behavior
of the cells between feeding times.

After 24 hours of the addition of the HUVECs to the CM culture, the beating rate was
improved by 29%. The maximum pace (42 bpm) was found 72 hours after the HUVEC addition
with an increment of 43% compared to pre-coculture samples. After 120 hours of HUVEC
implantation, the beating rate recorded was similar to the maximum; however, after 120 h the
pace started to decline, and the beating function diminished to 18 bpm by day 8.
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5.3 Discussion
For both observations with the two different ratios, it is interesting that when a medium
change was performed, the beating rate of the cells declined (orange markers in Fig. 5 and 6).
This decline in the pace of CMs is explained by the fact that the cells needed time to reabsorb
nutrients from the fresh medium that was fed to them; therefore 24 hours after the medium
change, once the cells assimilated the needed nutrients of the fresh medium, the beating function
was improved again. It is important to highlight that the medium changes were performed
outside of the incubator, thus the temperature of the cells changed, and that is another reason that
may explain the behavior of the cells at those feeding times.
The results were much better when the ratio of coculture was 2:1. The beating rate started
to improve just after 24 h of coculture and the maximum observed at this condition was 112
bpm. Additionally, the cells showed a more synchronized pace after the addition of the HUVECs
to the culture. However, the cells cultured at 1:1 ratio showed a slower beating rate compared
with the results obtained in the first observation. Even though the cells showed a similar trend,
by beating faster 120 h after the implantation of the HUVECs, the difference between the pace of
the cells cultured at 2:1 ratio compared with the cells cultured at 1:1 ratio at the same time was
63%, suggesting that a 2:1 ratio of coculture is better for the CMs behavior and functionality.
One of the major challenges with experiments done in vitro is to keep the cells beating
for longer periods of time. CMs do not proliferate once they reach a mature phenotype.
Therefore, they tend to stop their beating function and die due to the conditions of in vitro
culture. For both observations, the cells slowed their beating function after 6 days of coculture
and stopped beating completely by day 8 (23 days post differentiation). One of the biggest
reasons for this was the limited oxygen and nutrient supply when the cells were cultured in vitro.
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Even though endothelial cells are responsible for blood vessel formation, the lack of
characteristics similar to the native human heart environment prevented the cells from
performing their natural and normal function. Lastly, there are more types of cells present in the
native human heart such as cardiac fibroblasts and smooth muscle cells; to obtain a construct that
can better mimic the function of the native heart, all these cells must be added to the CM
cultures.
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6. Pharmacological Stimulation of 2D Monolayer CM Cultures
When CMs are cultured in vitro, unsynchronized beating function is one of the major
problems. The cells do not behave the same way that happens in the native heart, and this is one
of the biggest challenges to overcome in order to create a regenerative therapy that could assist in
the healing process of heart disease.
Some studies have been published that demonstrated how the addition of norepinephrine
to CMs leads to an improvement in the beating function, as well as in the contraction force of the
cells [33]. In this experiment, the CMs cultured in monolayers were stimulated with
norepinephrine at different concentrations. The cells were exposed to short periods of drug
stimuli, and the results were recorded, showing that the beating function of the cells increased,
compared to CMs without stimuli.

6.1 Materials and Methods
Cardiomyocytes were cultured as previously described in cell culture plates. At day 21
post differentiation, when the cells attained a mature phenotype, pharmacological stimulation
was performed. Cardiomyocytes were stimulated with a solution of norepinephrine (NE, Sigma
Aldrich®) at two different concentrations (10 and 20 µM) to evaluate the impact of the drug on
the cells. The stimulator medium was prepared by diluting the NE in Cardiomyocyte
Maintenance Medium (StemCell Technologies™) at the desired concentrations. The cells were
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beating weakly before stimulation was performed, and the rate was recorded before NE stimuli
by placing the cells in the microscope and recording their contraction. The stimulation assay was
performed following a protocol published by Fan et al [33]. Stimulator medium was added to the
cells for 10 minutes and the contraction of the cells was recorded (first round). After that, fresh
medium (without NE) was added to the cultures and the cells were observed for 60 minutes to
evaluate the impact of the drugs in the cells. Following the 60-minute period without NE,
stimulator medium was added again to the cells for 10 minutes (second round) and the
contraction response of the cells was recorded again. Another observation was done by keeping
the cells with stimulator medium for 60 minutes following the first period of stimulation, after
which the contraction rates were recorded again for 10 minutes.

6.2 Results
The first observation was performed with cells cultured on regular culture plates (6 wellplates) using a 10 µM stimulator medium. The pre-stimulation rate was recorded before the
addition of the drugs and the cell beating rate was 38 bpm (Figure 7). The Stimulator medium
was added to the cell cultures and the first observation was recorded 5 minutes after the addition
of the drugs. The CMs expressed a beating rate of 114 bpm (Fig 7, red arrow), an increment of
67% when compared with the beating rate of the cells before the stimulation. A second
measurement was recorded 10 minutes after the addition of the NE and it showed a beating rate
of 68 bpm. The beating function decreased by 40% compared with the measurement recorded 5
minutes after the stimulator was added to the cells, but the pace was better when compared with
the pre-stimulation rate. After the first round of stimulation, the medium was changed to remove
the stimulator and the beating function was recorded twice: 10 and 20 minutes after the removal
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of the stimulator. The first measurement showed 74 bpm and the second one 50 bpm. The
beating rate decreased 56% when compared with the pace of the cells that were in contact with
the stimulator for 5 minutes (114 bpm). After the stimulator was re-added to the cell cultures for
an additional 10 minutes, the beating rate sped up again reaching a pace of 106 bpm (Fig 7, green
arrow).

A. NE for 10-min

B. No NE for
60-min

C. NE for 10-min

Figure 7. Stimulation results with 10 µM (A) 10-min stimuli, (B) no stimuli for 60-min and
(C) 10-min stimuli. Red arrow shows bpm peak after first round of stimulus. Green arrow
shows bpm peak after second round of stimulus. Dotted line is plotted at the prestimulation rate as a reference.

The second observation was carried out similarly, but the cells were treated with 20 µM
NE stimulator; additionally, the recordings were performed in shorter intervals, 3 times in each
stimulation round (Figure 8). The CMs were beating at a pace of 26 bpm before the stimulation
with NE was performed (pre-stimulation rate, dash line on Fig. 8). Once the stimulator medium
was added to the cell cultures the contraction rate was recorded 5 minutes after the addition of
the drugs in intervals of 2 or 3 minutes. The first recording showed an increase of 21% of the
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contraction rate of the cells, and the peak was found to be at 5 minutes (Fig 8, red arrow) of drug
stimulation with an increment of 59% in comparison with the pre-stimulation rate. After the 10minute stimulation period, the stimulator medium was removed and changed for regular CM
medium. The cells were placed back in the incubator and the contraction rate was recorded. The
cells exhibited a contraction rate close to the pre-stimulation rate, with a change of only 7%.
After the 60-minute period without stimuli, the cells were stimulated again with NE and the
functional beating was recorded once again. CMs exhibited an increment in the contraction rate;
this time with a peak at 80 minutes (Fig 8, green arrow). The change in the contraction rate was
62% (69 bpm) compared to pre-stimulation rate (26 bpm).

A. NE for 10-min

B. No NE for 60min

C. NE for 10-min

Figure 8. Stimulation results with 20 µM (A) 10-min stimuli, (B) no stimuli for 60-min and
(C) 10-min stimuli. Red arrow shows bpm peak after first round of stimulus. Green arrow
shows bpm peak after second round of stimulus. Dotted line is plotted at the prestimulation rate as a reference.
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6.3 Discussion
Figure 9 shows the results for both pharmaceutical stimulation assays plotted together.

A. NE for 10-min

B. No NE for
60-min

C. NE for 10-min

Figure 9. Stimulation of CMs with NE. (A) 10-min period stimuli, (B) 60-min period
without stimuli, and (C) 10-min period stimuli. Assay 1 was performed with stimulator 10
µM NE and Assay 2 was performed with stimulator 20 µM NE.

For the first assay during the first round of stimulation, the cells exhibited a better
contraction rate when treated with 10 µM than cells treated with higher concentration of
stimulator (20 µM, second assay). The highest pace recorded in the assay performed with 10 µM
NE was 116 bpm, after 5 minutes of stimulation (Fig. 9A red arrow). When the stimulator was
added after a 60-min period of non-stimuli, the increase in the CM beating rate was similar to the
initial response (Fig. 9C red arrow). However, for the second assay the pace decreased compared
with the results obtained from the first assay (Fig. 9A green arrow). The cells exhibited a slower
beating rate, being 69 bpm, the highest pace achieved by the cells after the second round of
stimulation (Fig. 9C green arrow). These results led to several observations. First, the
concentration of the drugs creates a response from the cells. The cells exhibited improved
contraction rates when the concentration of the stimulator medium was 10 µM as observed
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previously by Fan et al [33]. In contrast, the measurements made in both assays after 5 min of
stimulation showed that the beating rate of the cells decreased by 45% (114 bpm, 5 min after
stimulation with 10 µM NE versus 63 bpm, 5 min after stimulation with 20 µM NE) when the
stimulator concentration was doubled during assay 2. Second, we hypothesize that the
temperature of the cells is an important variable that affects the beating function of the CMs. The
temperature of the CMs in the human heart is 37°C; taking the culture plates out of the incubator
several times may decrease the temperature of the cultures and therefore, their beating function.
This hypothesis arose based on the results obtained from the first assay, when the cells were only
taken outside of the incubator to record the beating rate twice instead of three times as done in
the second assay. Third, for both assays, the 60-min period without stimuli showed a decrease in
the beating function (Fig. 9 B), which was slower for assay 1 and faster for assay 2; but no
improvement in the beating function was observed. The last observation suggests that the cells
do need the stimuli of the drugs to improve the beating function. Norepinephrine is an antagonist
released by the sympathetic system in the human body. This antagonist binds to the beta
receptors (β2) located in the membrane of the cells and the response is to increase the beating
function of the CMs when the pace slows down.
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7. Inosculation of Engineered Heart Tissue
The creation of heart tissue engineered constructs is only the beginning step in the
development of a regenerative therapy to treat heart failure disease. The remaining challenge is
the establishment of an efficient communication between the beating patch with the host and to
maintain this connection to ensure the survival of the heart tissue constructs. This survival can be
ensured by creating a vascularized tissue that can connect to the host. Vascularization may be
achieved by the stimulation of angiogenesis or the inosculation of preformed microvascular
networks within the implants to the host microvasculature [35]. See Figure 10.
In all types of human tissues, the endothelial cells are responsible for the creation of the
vasculature. These cells are connected to each other by tight junctions that enable the
communication between cells. There are specific proteins that are part of the tight junctions
known as Claudins which are located in the membrane of the cells. These proteins are the most
important components of the tight junctions, and are responsible for the establishment of the
paracellular barrier that controls the flow of molecules in the intercellular space between the cells
of the epithelium [36]. Endothelial cells express claudins 1, 2, 3, 4, 7, 9 and 14. Most of the
processes that occur inside a cell require energy, and the cells have three sources: chemical,
electrical, and mechanical. Mechanical forces are translated into biochemical activity of the cell
and involves the interaction of many structural components including the extracellular matrix,
the cytoskeleton, the lipid bilayer, and the intracellular organelles [37].
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Figure 10. Angiogenesis (left) vs. Inosculation (right). In angiogenesis, new blood vessels
sprout and grow into the implant (gray). During inosculation (circles), existing blood
vessels (blue) connect to host blood vessels (red).
Tight junctions and specifically, their membrane proteins known as claudins, are capable
of interacting with all the mentioned cellular sites to transduce mechanical forces. Inosculation
can improve the angiogenic host tissue response and accelerate the directed growth of
microvessels from the host microvasculature towards the implants and potentially eliminate the
rejection of the tissue constructs by the host.
In this preliminary study, the potential that claudins have in healing the membrane of
damaged HUVECs was demonstrated. Future studies are required to better understand the
restoration of the mechanotransduction machinery through the introduction of soluble dual
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surface chimeric claudins, as this restoration can be turned into advantages in the process of
inosculation of tissues.
In our initial experiment with endothelial cells, HUVECS (Cell Applications, Inc.) were
cultured in T-75 flasks using Endothelial Cell Growth Medium (Cell Applications Inc). The cells
were thawed, resuspended in Endothelial Growth Medium (15 ml per flask) and incubated at
37°C in a 5% CO2 incubator. The medium was changed one day after seeding to remove traces
of DMSO, and thereafter, fresh medium was added to the cell cultures every other day. Once the
cell population reached ~90%, the cells were passaged using Trypsin/EDTA (Cell Applications
Inc.) as a dissociation reagent following the protocol provided by the manufacturer. The cells
were passaged onto a 12-well plate and grew to confluency. The monolayer was wounded using
a 200 µL pipette tip by applying just enough pressure to damage the monolayer but not scratch
the surface of the well plate. Pictures were taken to identify the wound gap in each well using a
light transmission microscope. For the positive test, the dual surface claudins (chCLDNs)[38]
were added to the HUVEC medium at a concentration of 1 µM, and for a negative control, single
surface claudins (chCLDNs with “one end”) were added to the HUVEC medium at the same
concentration. One extra observation was performed only with HUVEC medium. The cells were
incubated for 3h, 6h and 24h at 37°C in a 5% CO2 incubator, and pictures were taken at each
interval of time at the same spot every time to evaluate the gap closure for each observation.

Preliminary Results
After the wound was made on the monolayers, pictures were taken using a light
transmission microscope, and measurements of each gap (3 samples; 3 times each one) were
recorded before the addition of the dual (test) and single (control) chCLDNS. Gap measurements
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were made 3, 6, and 24 hours after the addition of the proteins to assess their effects on the
closure of the wounded monolayers.
dual chCLDNS

0h

A

single chCLDNS
I

E

554 µm

B

Medium only

629 µm

817 µm

J

F
695 µm

3h

445 µm
512 µm

C

341 µm

6h

595 µm
295 µm

D

24 h

K

G

H

L

529 µm

Figure 11. Wound healing assay. (A), (E), (I) wounded HUVEC monolayer before addition
of proteins, (B), (C), (D) cells treated with dual chCLDNS 3, 6 and 24 h after treatment, (F),
(G), (H) cells treated with single chCLDNS 3, 6 and 24 h after treatment and (J), (K), (L)
cells treated with HUVEC medium only. Scale bars represent 100 µm.
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The results from this preliminary experiment indicated that there was an influence of the
chimeric claudins on the membrane proteins of the cells. The images obtained 3h after the
addition of the dual chCLDNS showed that the monolayer wound began to close when compared
with the original gap length (Fig. 11B). The average length of the original wound was 554 µm
and the length recorded 3h after the addition of the proteins was 445 µm. The wound closed
about 23%±9% of its original length. After six hours of treatment the closure was 295 µm,
48%±9% of the original gap length (Fig 11C).

Figure 12. Dual surface claudins increase the gap closure rate in wounded cells in
comparison with cells treated with single surface claudins and only cell culture medium.
For the final stage of the experiment, the data were recorded 24 h after the addition of the
proteins. For this stage of the experiment, both the gap on the positive control and on the samples
treated with medium closed completely. However, in the negative control, the gap closure was
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just 11% (Fig. 10H, Fig. 12) suggesting that the cells do need protein with both endings to be
able to completely heal and close the wound. The samples treated with just regular cell medium
closed completely after 24 h due to the natural proliferation function of the cells.

Discussion
It is important to understand how every tissue works in the human body. The heart
muscle needs more than cardiomyocytes to perform its job. Trying to mimic the behavior of the
heart muscle must include all the connections and the environment that the native human heart
has. In addition to including support cells, the connections made by those cells need to be
understood. For this preliminary experiment, the hypothesis is that the single surface claudins
occupied sites on the membrane preventing the cell from reestablishing the connections with the
cells in the vicinity, and that is why the gap on the negative controls did not close completely.
Additionally, the cells treated with dual surface claudins were able to heal and completely
close the wound, suggesting that claudins with both ends are necessary in the healing process of
the membrane of the cells because they aid in reestablishing the communication with the cells in
the vicinity. Comparing these observations with the results obtained when the wound was treated
only with medium, the conclusion is that the cells closed the wound in the experiment including
only medium because they proliferated and populated the space. Better observations must be
done to understand the behavior of the cell membrane and the responses of the membrane
proteins when the single surface claudins were added to the samples. The introduction of the
inosculation concept in the research of regenerative therapies in the cardiovascular field could
promise better and faster results in obtaining in vitro models that can be incorporated into in vivo
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models to develop a therapy that can deliver better results in the treatment of heart failure
disease.
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8. Thesis Synopsis
8.1 Conclusions
Several concepts need to be considered when evaluating the possibility of creating a new
regenerative therapy that can help patients suffering from heart failure disease. The heart is the
main motor of the human body; it is responsible to deliver the blood that carries oxygen and vital
nutrients for the correct function of every single tissue and cell that composes the human
anatomy. The correct functioning of the heart is vital for correct function of the human body;
therefore, the therapies targeted to aim in the healing of the damaged heart need to be very
specific and almost perfect. This raises a lot of questions and leads to different scenarios of how
regenerative medicine can be applied to help heart patients now and in the near future.
In chapter 5, the viability of creating a beating tissue construct by recellularization of
decellularized porcine cECM was demonstrated. For this study several conclusions were made.
First, it was shown how the IPS cells-derived CMs were able to grow and complete the
differentiation process to fully mature CMs on the decellularized porcine cECM. Additionally,
the cECM was shown to be a scaffold suitable for cell development, growth and expansion,
without any cytotoxic effects. The populated cECM continued to beat for up to 90 days, with
beating rate up to 113 bpm, creating a heart tissue construct that could be incorporated as a
regenerative therapy that could aim toward the healing of the damaged heart of patients suffering
from heart failure disease.
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Second, and one of the major findings in this study is that the cECM provided an
exceptional environment for CM development, not only because it does not have any cytotoxic
effect on the cells, but also because the CMs are able to organize in fibrils and create connections
with the fibroblasts, setting-up an oriented network of fibroblasts and CMs similar what is
observed in the native human heart.
Third, the conditions of the implantation of the CMs onto the matrix have an important
role in the creation of the beating tissue constructs. The cells were able to penetrate and create an
organized network within the cECM when they finished the differentiation process in the matrix.
The implantation was performed at day 4 of differentiation when the CMs were in a progenitor
stage, meaning that they still had the ability to proliferate and organize themselves within the
collagen fibers of the cECM. However, when the differentiation process was carried out in
regular culture plates and the recellularization of the cECM was done with mature CMs, once the
implantation occurred, the cells had lost the ability to proliferate. In addition, their ability to
burrow and interact with the collagen fibers of the matrix was decreased; thus, the CMs formed
layers of cells on top of the cECM instead of burrowing deep inside the matrix. These layers did
not interact with the fibroblasts as well as when the implantation was done with progenitor CMs,
and that led to a non-oriented network of cells that affected the beating function of the CMs,
leading to desynchronized beating patterns within the matrix, and therefore a defective beating
tissue construct that would not be suitable for heart tissue regeneration.
In chapter 6, the potential of the addition of support cells such as HUVECs to the 2D
monolayer cultures to improve the beating function of the cells was demonstrated. In the native
human heart, along with CMs, there are several types of cells such as endothelial cells and
fibroblasts that are responsible for the correct functioning of the heart tissue. In this study,
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HUVECs were added to the 2D monolayer culture of CMs to evaluate the impact of these cells
in the CMs and their functioning, and several conclusions arose. First, the HUVECs added in
correct ratios (2:1 HUVEC:CM) improved the beating function of the CM cultures. The beating
rate recorded improved after 24 h of treatment by 59%, and after 120 h of coculture the cells
expressed a beating pace of 112 bpm (77% improvement compared to cell culture with only
CMs). However, when the coculture ratio was of 1:1 HUVEC:CM, the results were worse. The
beating function improved only 41%, 42 bpm being the maximum pace.
Second, it was observed that at feeding times, when the medium of the cell cultures was
changed, the beating function diminished. Since these experiments were done in vitro, the
beating function of the cells changed drastically and slowed down because the cells needed time
to adapt to the fresh medium. The medium change was performed outside of the incubator, at
room temperature and that influenced the beating rate of the cells, contrary to what happens in
vivo, when the nutrients are delivered to the cells with no change in temperature.
Finally, the support cells (in this case the endothelial cells), along with the ratio of
coculture play an important role in the correct functioning of the CMs, and it is reflected in their
beating rate being the 2:1 ratio (HUVEC:CM coculture), a better approximation of the behavior
of the cells in the native human heart.
Another approach that is commonly used to speed up the pace of the cells and improve
their beating rate is the addition of drugs in the culture medium. Cardiomyocytes have beta
receptors (β2) located in their membrane. In the presence of antagonist drugs such as
Norepinephrine, there is an improvement in the CM beating rate. In chapter 7, the impact of
pharmacological stimulation performed on the CMs was shown. From this portion of the study,
one can conclude that the CMs cultured in vitro need the action of the drugs on its membrane to
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correctly perform their beating function. Norepinephrine, a neurotransmitter, is secreted by the
adrenal glands and targets several tissues including the heart. In the native human heart, the
sympathetic branch of the nervous system is responsible to adjustments in the beating pace of the
heart by the action of norepinephrine; it increases the beating rate when needed to keep up the
normal pace of the heart.
Also, the amount of drug that the cells should be exposed to is limited to a concentration
of 10 µM. When the cells were exposed to that concentration, the beating rate was improved
from 30 bpm to 116 bpm after 5 minutes of drug stimulation. However, when the CMs were
exposed to a higher concentration of drugs (20 µM) the beating rate was only improved to 69
bpm. Even though the beating rate for the second observation falls into the regular beating rate of
an adult human at rest, these observations were performed in vitro in regular culture plates, and a
faster pace will be required when the cells are passaged onto the cECM due to the difficulties of
the CMs to beat faster and stronger within the matrix.

8.2 Recommendations for Future Work
In chapter 7, the inosculation of the heart tissue constructs was proposed. The preliminary
study done with HUVECs suggested the possibility of incorporating surface proteins found in the
membrane of the cells. The experiment was performed with HUVECs because of the simplicity
of the culture protocol, and the availability of the dual claudins at BYU. The endothelial cells
used in this study belong to the family of cells that possess in their membrane this particular
claudin protein. The presence of endothelial cells in the cardiac cultures is essential for the
correct functionality of the CMs, being also an important consideration when creating the 3D
cardiac tissue constructs using decellularized cECM for future studies. As endothelial cells play
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an essential role in the angiogenesis of the tissues, vascularization may be achieved by the
stimulation of angiogenesis or the inosculation of preformed microvascular networks within the
implants to the host microvasculature, moving this tissue engineering technology one more step
toward patient treatments.
The mechanotransduction events that occur inside the cell remain unknown and the
understanding of these processes could lead to new findings that can improve the creation of a
more complete cardiac regenerative therapy. As endothelial cells have these proteins in their
tight junctions, the CMs have proteins in their gap junctions known as connexins that allow the
communication between cells and the transferring of the electrical impulses responsible for the
creation of the contraction of the cells. Understanding the biology at the membrane of the cells
could lead to more findings related to the limited capacity of the CMs to heal in the cardiac
tissue.
Mechanical stretching has been proven to be a useful resource to obtain contractile
cardiac tissue patches with cell alignment similar to the organization in the human heart muscle.
The incorporation of the preliminary mechanical prototype designed and assembled in the
laboratory (Fig. 13) to stretch and stimulate the 3D beating tissue construct, is important to
obtain a stronger and more mature beating patch that could mimic the function of the native
human heart tissue.
The recommendation is to mechanically stretch the tissue construct that has been
populated not only with CMs but also with other support cells such as endothelial cells and
cardiac fibroblasts. In addition, electrical stimulation must be included for future studies, since it
has been proven that electrical stimuli result in the maturation of the CMs and in the alignment
of them. Based on the literature, I propose a mechanical stimulation performed by cyclical
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stretch of 5% to 8% for 48 hours and electrical stimulation with frequencies in the range of 11.67 Hz.

Figure 13. Mechanical Stretcher Prototype Built in Our Lab.
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